No Data
Weekly Buzz: Finally a Good Week for 2025
Odyssey Therapeutics Files for $100M IPO
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
'Ozempic Is In The Next Round Of Medicare Drug Price Negotiations. See The Full List Of 15 Medications' - CNBC
Pre-market drop of over 4%! Novo-Nordisk A/S's "weight loss miracle drug" enters price negotiations with USA healthcare.
The diabetes drug Ozempic and the weight loss drug Wegovy, among 15 other medications from Novo-Nordisk A/S, have been included in the USA government’s plan for Medicare price negotiations scheduled for 2027. After this announcement, Novo-Nordisk A/S's stock price was surpassed by LVMH, making it the second largest publicly traded company in Europe.